Nature Biotechnology | Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic aging clocks
New study demonstrates TanSat-2's potential to distinguish human carbon emissions from ecosystem carbon sinks
Landmark pancreatic cancer drug shows potential against lung cancer too